Significant growth trajectory of the Breast Cancer Application segment, which is expected to reach US$374.1 Million by 2030 ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of waveLINE-010, a pivotal ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve ...

A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.

A study reveals a novel adhesive patch prototype using AgNP-Cx+ for enhanced anti-tumor activity against melanoma, showcasing ...

A doctor at a local cancer institute hopes to do more clinical studies to see if lab findings apply to actual patients. Read ...

Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...

A new study published in Drug Design, Development and Therapy suggests that cannabidiol (CBD) may help protect the heart from ...